Extendicare Inc. (TSE:EXE – Get Free Report) has earned a consensus recommendation of “Buy” from the eight ratings firms that are covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold rating, four have given a buy rating and three have assigned a strong buy rating to the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is C$24.50.
EXE has been the subject of several analyst reports. BMO Capital Markets raised Extendicare from a “hold” rating to an “outperform” rating and lifted their price objective for the company from C$21.00 to C$24.00 in a report on Thursday, December 4th. National Bankshares raised their price target on Extendicare from C$24.50 to C$29.00 and gave the stock an “outperform” rating in a research report on Thursday. TD Securities boosted their price target on Extendicare from C$15.00 to C$19.00 in a research note on Thursday, November 13th. Natl Bk Canada raised shares of Extendicare to a “strong-buy” rating in a research report on Wednesday, December 3rd. Finally, Cormark increased their price objective on shares of Extendicare from C$25.00 to C$30.00 in a research note on Wednesday, December 3rd.
Check Out Our Latest Research Report on EXE
Extendicare Stock Performance
Extendicare Company Profile
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
See Also
- Five stocks we like better than Extendicare
- Free: The Crypto Summit That Could Change Your Life
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- What a Former CIA Agent Knows About the Coming Collapse
- NEW LAW: Congress Approves Setup For Digital Dollar?
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
